nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—PTGIR—pulmonary artery—sarcoma	0.0902	0.287	CbGeAlD
Treprostinil—PPARD—mammary gland—sarcoma	0.0296	0.0943	CbGeAlD
Treprostinil—PTGIR—endothelium—sarcoma	0.0282	0.0898	CbGeAlD
Treprostinil—P2RY12—hematopoietic system—sarcoma	0.0217	0.0692	CbGeAlD
Treprostinil—PPARD—hematopoietic system—sarcoma	0.0181	0.0575	CbGeAlD
Treprostinil—PTGIR—hematopoietic system—sarcoma	0.0139	0.0441	CbGeAlD
Treprostinil—PTGIR—connective tissue—sarcoma	0.0134	0.0425	CbGeAlD
Treprostinil—PPARD—lymphoid tissue—sarcoma	0.0127	0.0405	CbGeAlD
Treprostinil—PTGIR—smooth muscle tissue—sarcoma	0.0122	0.0389	CbGeAlD
Treprostinil—PPARD—tendon—sarcoma	0.012	0.038	CbGeAlD
Treprostinil—PPARD—testis—sarcoma	0.0099	0.0315	CbGeAlD
Treprostinil—PPARD—liver—sarcoma	0.00936	0.0298	CbGeAlD
Treprostinil—CYP2C9—mammary gland—sarcoma	0.00813	0.0259	CbGeAlD
Treprostinil—PTGIR—testis—sarcoma	0.0076	0.0242	CbGeAlD
Treprostinil—PTGIR—liver—sarcoma	0.00718	0.0229	CbGeAlD
Treprostinil—PPARD—lymph node—sarcoma	0.00717	0.0228	CbGeAlD
Treprostinil—PTGIR—lymph node—sarcoma	0.00551	0.0175	CbGeAlD
Treprostinil—CYP2C9—hematopoietic system—sarcoma	0.00496	0.0158	CbGeAlD
Treprostinil—CYP2C9—liver—sarcoma	0.00257	0.00817	CbGeAlD
Treprostinil—Ecchymosis—Doxorubicin—sarcoma	0.00226	0.00332	CcSEcCtD
Treprostinil—Flushing—Etoposide—sarcoma	0.00225	0.0033	CcSEcCtD
Treprostinil—Myalgia—Vincristine—sarcoma	0.00222	0.00325	CcSEcCtD
Treprostinil—Cough—Mitoxantrone—sarcoma	0.00221	0.00324	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00218	0.0032	CcSEcCtD
Treprostinil—Sepsis—Doxorubicin—sarcoma	0.00217	0.00318	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00217	0.00318	CcSEcCtD
Treprostinil—Cardiac failure congestive—Epirubicin—sarcoma	0.00216	0.00317	CcSEcCtD
Treprostinil—Myalgia—Mitoxantrone—sarcoma	0.00216	0.00316	CcSEcCtD
Treprostinil—Arthralgia—Mitoxantrone—sarcoma	0.00216	0.00316	CcSEcCtD
Treprostinil—Chest pain—Mitoxantrone—sarcoma	0.00216	0.00316	CcSEcCtD
Treprostinil—Paraesthesia—Thiotepa—sarcoma	0.00215	0.00315	CcSEcCtD
Treprostinil—Anxiety—Mitoxantrone—sarcoma	0.00215	0.00315	CcSEcCtD
Treprostinil—Discomfort—Mitoxantrone—sarcoma	0.00213	0.00313	CcSEcCtD
Treprostinil—Oedema—Vincristine—sarcoma	0.00213	0.00311	CcSEcCtD
Treprostinil—Infection—Vincristine—sarcoma	0.00211	0.00309	CcSEcCtD
Treprostinil—Dyspepsia—Thiotepa—sarcoma	0.00211	0.00309	CcSEcCtD
Treprostinil—Thrombophlebitis—Doxorubicin—sarcoma	0.0021	0.00308	CcSEcCtD
Treprostinil—Decreased appetite—Thiotepa—sarcoma	0.00208	0.00305	CcSEcCtD
Treprostinil—Thrombocytopenia—Vincristine—sarcoma	0.00208	0.00305	CcSEcCtD
Treprostinil—Oedema—Mitoxantrone—sarcoma	0.00207	0.00303	CcSEcCtD
Treprostinil—Decreased appetite—Dactinomycin—sarcoma	0.00207	0.00303	CcSEcCtD
Treprostinil—Fatigue—Thiotepa—sarcoma	0.00207	0.00303	CcSEcCtD
Treprostinil—Infection—Mitoxantrone—sarcoma	0.00206	0.00301	CcSEcCtD
Treprostinil—Fatigue—Dactinomycin—sarcoma	0.00205	0.00301	CcSEcCtD
Treprostinil—Pain—Thiotepa—sarcoma	0.00205	0.003	CcSEcCtD
Treprostinil—Back pain—Etoposide—sarcoma	0.00204	0.00299	CcSEcCtD
Treprostinil—Shock—Mitoxantrone—sarcoma	0.00204	0.00298	CcSEcCtD
Treprostinil—Pain—Dactinomycin—sarcoma	0.00203	0.00298	CcSEcCtD
Treprostinil—Muscle spasms—Etoposide—sarcoma	0.00203	0.00297	CcSEcCtD
Treprostinil—Thrombocytopenia—Mitoxantrone—sarcoma	0.00203	0.00297	CcSEcCtD
Treprostinil—Anorexia—Vincristine—sarcoma	0.00203	0.00297	CcSEcCtD
Treprostinil—Tachycardia—Mitoxantrone—sarcoma	0.00202	0.00296	CcSEcCtD
Treprostinil—Cardiac failure—Epirubicin—sarcoma	0.00201	0.00295	CcSEcCtD
Treprostinil—Cardiac failure congestive—Doxorubicin—sarcoma	0.002	0.00294	CcSEcCtD
Treprostinil—Hypotension—Vincristine—sarcoma	0.00199	0.00291	CcSEcCtD
Treprostinil—Feeling abnormal—Thiotepa—sarcoma	0.00197	0.00289	CcSEcCtD
Treprostinil—Anorexia—Mitoxantrone—sarcoma	0.00197	0.00289	CcSEcCtD
Treprostinil—Pain in extremity—Epirubicin—sarcoma	0.00196	0.00288	CcSEcCtD
Treprostinil—Feeling abnormal—Dactinomycin—sarcoma	0.00196	0.00287	CcSEcCtD
Treprostinil—Gastrointestinal pain—Thiotepa—sarcoma	0.00196	0.00287	CcSEcCtD
Treprostinil—Ill-defined disorder—Etoposide—sarcoma	0.00196	0.00287	CcSEcCtD
Treprostinil—Anaemia—Etoposide—sarcoma	0.00195	0.00286	CcSEcCtD
Treprostinil—Gastrointestinal pain—Dactinomycin—sarcoma	0.00194	0.00285	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Vincristine—sarcoma	0.00194	0.00284	CcSEcCtD
Treprostinil—Hypotension—Mitoxantrone—sarcoma	0.00193	0.00283	CcSEcCtD
Treprostinil—Insomnia—Vincristine—sarcoma	0.00192	0.00282	CcSEcCtD
Treprostinil—Paraesthesia—Vincristine—sarcoma	0.00191	0.0028	CcSEcCtD
Treprostinil—Malaise—Etoposide—sarcoma	0.0019	0.00279	CcSEcCtD
Treprostinil—Abdominal pain—Thiotepa—sarcoma	0.00189	0.00278	CcSEcCtD
Treprostinil—Body temperature increased—Thiotepa—sarcoma	0.00189	0.00278	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00189	0.00276	CcSEcCtD
Treprostinil—Abdominal pain—Dactinomycin—sarcoma	0.00188	0.00276	CcSEcCtD
Treprostinil—Body temperature increased—Dactinomycin—sarcoma	0.00188	0.00276	CcSEcCtD
Treprostinil—Cardiac failure—Doxorubicin—sarcoma	0.00186	0.00273	CcSEcCtD
Treprostinil—Paraesthesia—Mitoxantrone—sarcoma	0.00186	0.00272	CcSEcCtD
Treprostinil—Loss of consciousness—Etoposide—sarcoma	0.00185	0.00272	CcSEcCtD
Treprostinil—Decreased appetite—Vincristine—sarcoma	0.00185	0.00271	CcSEcCtD
Treprostinil—Dyspnoea—Mitoxantrone—sarcoma	0.00185	0.0027	CcSEcCtD
Treprostinil—Cough—Etoposide—sarcoma	0.00184	0.0027	CcSEcCtD
Treprostinil—Fatigue—Vincristine—sarcoma	0.00183	0.00269	CcSEcCtD
Treprostinil—Dehydration—Epirubicin—sarcoma	0.00183	0.00268	CcSEcCtD
Treprostinil—Dyspepsia—Mitoxantrone—sarcoma	0.00182	0.00267	CcSEcCtD
Treprostinil—Pain—Vincristine—sarcoma	0.00182	0.00266	CcSEcCtD
Treprostinil—Pain in extremity—Doxorubicin—sarcoma	0.00182	0.00266	CcSEcCtD
Treprostinil—Decreased appetite—Mitoxantrone—sarcoma	0.0018	0.00264	CcSEcCtD
Treprostinil—Chest pain—Etoposide—sarcoma	0.0018	0.00263	CcSEcCtD
Treprostinil—Hypokalaemia—Epirubicin—sarcoma	0.00179	0.00262	CcSEcCtD
Treprostinil—Fatigue—Mitoxantrone—sarcoma	0.00178	0.00262	CcSEcCtD
Treprostinil—Discomfort—Etoposide—sarcoma	0.00177	0.0026	CcSEcCtD
Treprostinil—Pain—Mitoxantrone—sarcoma	0.00177	0.00259	CcSEcCtD
Treprostinil—Gastrointestinal pain—Vincristine—sarcoma	0.00174	0.00255	CcSEcCtD
Treprostinil—Asthenia—Thiotepa—sarcoma	0.00172	0.00252	CcSEcCtD
Treprostinil—Infection—Etoposide—sarcoma	0.00171	0.00251	CcSEcCtD
Treprostinil—Asthenia—Dactinomycin—sarcoma	0.00171	0.0025	CcSEcCtD
Treprostinil—Feeling abnormal—Mitoxantrone—sarcoma	0.00171	0.0025	CcSEcCtD
Treprostinil—Influenza—Epirubicin—sarcoma	0.0017	0.00249	CcSEcCtD
Treprostinil—Pruritus—Thiotepa—sarcoma	0.0017	0.00249	CcSEcCtD
Treprostinil—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00169	0.00248	CcSEcCtD
Treprostinil—Dehydration—Doxorubicin—sarcoma	0.00169	0.00248	CcSEcCtD
Treprostinil—Thrombocytopenia—Etoposide—sarcoma	0.00169	0.00247	CcSEcCtD
Treprostinil—Tachycardia—Etoposide—sarcoma	0.00168	0.00246	CcSEcCtD
Treprostinil—Abdominal pain—Vincristine—sarcoma	0.00168	0.00246	CcSEcCtD
Treprostinil—Body temperature increased—Vincristine—sarcoma	0.00168	0.00246	CcSEcCtD
Treprostinil—Hypokalaemia—Doxorubicin—sarcoma	0.00165	0.00242	CcSEcCtD
Treprostinil—Anorexia—Etoposide—sarcoma	0.00164	0.0024	CcSEcCtD
Treprostinil—Diarrhoea—Thiotepa—sarcoma	0.00164	0.0024	CcSEcCtD
Treprostinil—Body temperature increased—Mitoxantrone—sarcoma	0.00164	0.0024	CcSEcCtD
Treprostinil—Abdominal pain—Mitoxantrone—sarcoma	0.00164	0.0024	CcSEcCtD
Treprostinil—Bronchitis—Epirubicin—sarcoma	0.00163	0.00239	CcSEcCtD
Treprostinil—Diarrhoea—Dactinomycin—sarcoma	0.00163	0.00239	CcSEcCtD
Treprostinil—Hypotension—Etoposide—sarcoma	0.00161	0.00236	CcSEcCtD
Treprostinil—Dizziness—Thiotepa—sarcoma	0.00158	0.00232	CcSEcCtD
Treprostinil—Influenza—Doxorubicin—sarcoma	0.00157	0.0023	CcSEcCtD
Treprostinil—Paraesthesia—Etoposide—sarcoma	0.00155	0.00227	CcSEcCtD
Treprostinil—Dyspnoea—Etoposide—sarcoma	0.00153	0.00225	CcSEcCtD
Treprostinil—Asthenia—Vincristine—sarcoma	0.00152	0.00223	CcSEcCtD
Treprostinil—Vomiting—Thiotepa—sarcoma	0.00152	0.00223	CcSEcCtD
Treprostinil—Pneumonia—Epirubicin—sarcoma	0.00152	0.00223	CcSEcCtD
Treprostinil—Vomiting—Dactinomycin—sarcoma	0.00151	0.00222	CcSEcCtD
Treprostinil—Rash—Thiotepa—sarcoma	0.00151	0.00221	CcSEcCtD
Treprostinil—Bronchitis—Doxorubicin—sarcoma	0.00151	0.00221	CcSEcCtD
Treprostinil—Dermatitis—Thiotepa—sarcoma	0.00151	0.00221	CcSEcCtD
Treprostinil—Headache—Thiotepa—sarcoma	0.0015	0.0022	CcSEcCtD
Treprostinil—Rash—Dactinomycin—sarcoma	0.0015	0.0022	CcSEcCtD
Treprostinil—Decreased appetite—Etoposide—sarcoma	0.0015	0.00219	CcSEcCtD
Treprostinil—Asthenia—Mitoxantrone—sarcoma	0.00148	0.00218	CcSEcCtD
Treprostinil—Fatigue—Etoposide—sarcoma	0.00148	0.00218	CcSEcCtD
Treprostinil—Pain—Etoposide—sarcoma	0.00147	0.00216	CcSEcCtD
Treprostinil—Urinary tract infection—Epirubicin—sarcoma	0.00147	0.00216	CcSEcCtD
Treprostinil—Diarrhoea—Vincristine—sarcoma	0.00145	0.00213	CcSEcCtD
Treprostinil—Haematuria—Epirubicin—sarcoma	0.00144	0.00211	CcSEcCtD
Treprostinil—Epistaxis—Epirubicin—sarcoma	0.00143	0.00209	CcSEcCtD
Treprostinil—Nausea—Thiotepa—sarcoma	0.00142	0.00209	CcSEcCtD
Treprostinil—Sinusitis—Epirubicin—sarcoma	0.00142	0.00208	CcSEcCtD
Treprostinil—Feeling abnormal—Etoposide—sarcoma	0.00142	0.00208	CcSEcCtD
Treprostinil—Diarrhoea—Mitoxantrone—sarcoma	0.00142	0.00208	CcSEcCtD
Treprostinil—Nausea—Dactinomycin—sarcoma	0.00141	0.00207	CcSEcCtD
Treprostinil—Pneumonia—Doxorubicin—sarcoma	0.00141	0.00206	CcSEcCtD
Treprostinil—Gastrointestinal pain—Etoposide—sarcoma	0.00141	0.00206	CcSEcCtD
Treprostinil—Dizziness—Vincristine—sarcoma	0.00141	0.00206	CcSEcCtD
Treprostinil—Bradycardia—Epirubicin—sarcoma	0.00138	0.00203	CcSEcCtD
Treprostinil—Haemoglobin—Epirubicin—sarcoma	0.00137	0.002	CcSEcCtD
Treprostinil—Rhinitis—Epirubicin—sarcoma	0.00136	0.002	CcSEcCtD
Treprostinil—Body temperature increased—Etoposide—sarcoma	0.00136	0.00199	CcSEcCtD
Treprostinil—Abdominal pain—Etoposide—sarcoma	0.00136	0.00199	CcSEcCtD
Treprostinil—Urinary tract infection—Doxorubicin—sarcoma	0.00136	0.00199	CcSEcCtD
Treprostinil—Haemorrhage—Epirubicin—sarcoma	0.00136	0.00199	CcSEcCtD
Treprostinil—Vomiting—Vincristine—sarcoma	0.00135	0.00198	CcSEcCtD
Treprostinil—Pharyngitis—Epirubicin—sarcoma	0.00135	0.00198	CcSEcCtD
Treprostinil—Rash—Vincristine—sarcoma	0.00134	0.00196	CcSEcCtD
Treprostinil—Dermatitis—Vincristine—sarcoma	0.00134	0.00196	CcSEcCtD
Treprostinil—Oedema peripheral—Epirubicin—sarcoma	0.00134	0.00196	CcSEcCtD
Treprostinil—Haematuria—Doxorubicin—sarcoma	0.00133	0.00196	CcSEcCtD
Treprostinil—Headache—Vincristine—sarcoma	0.00133	0.00195	CcSEcCtD
Treprostinil—Epistaxis—Doxorubicin—sarcoma	0.00132	0.00194	CcSEcCtD
Treprostinil—Vomiting—Mitoxantrone—sarcoma	0.00132	0.00193	CcSEcCtD
Treprostinil—Sinusitis—Doxorubicin—sarcoma	0.00131	0.00192	CcSEcCtD
Treprostinil—Rash—Mitoxantrone—sarcoma	0.0013	0.00191	CcSEcCtD
Treprostinil—Dermatitis—Mitoxantrone—sarcoma	0.0013	0.00191	CcSEcCtD
Treprostinil—Headache—Mitoxantrone—sarcoma	0.0013	0.0019	CcSEcCtD
Treprostinil—Bradycardia—Doxorubicin—sarcoma	0.00128	0.00188	CcSEcCtD
Treprostinil—Haemoglobin—Doxorubicin—sarcoma	0.00126	0.00185	CcSEcCtD
Treprostinil—Nausea—Vincristine—sarcoma	0.00126	0.00185	CcSEcCtD
Treprostinil—Flushing—Epirubicin—sarcoma	0.00126	0.00185	CcSEcCtD
Treprostinil—Rhinitis—Doxorubicin—sarcoma	0.00126	0.00185	CcSEcCtD
Treprostinil—Haemorrhage—Doxorubicin—sarcoma	0.00126	0.00184	CcSEcCtD
Treprostinil—Pharyngitis—Doxorubicin—sarcoma	0.00125	0.00183	CcSEcCtD
Treprostinil—Oedema peripheral—Doxorubicin—sarcoma	0.00124	0.00181	CcSEcCtD
Treprostinil—Asthenia—Etoposide—sarcoma	0.00124	0.00181	CcSEcCtD
Treprostinil—Nausea—Mitoxantrone—sarcoma	0.00123	0.0018	CcSEcCtD
Treprostinil—Pruritus—Etoposide—sarcoma	0.00122	0.00179	CcSEcCtD
Treprostinil—Erythema—Epirubicin—sarcoma	0.00118	0.00173	CcSEcCtD
Treprostinil—Diarrhoea—Etoposide—sarcoma	0.00118	0.00173	CcSEcCtD
Treprostinil—Flushing—Doxorubicin—sarcoma	0.00117	0.00171	CcSEcCtD
Treprostinil—Tension—Epirubicin—sarcoma	0.00116	0.0017	CcSEcCtD
Treprostinil—Nervousness—Epirubicin—sarcoma	0.00115	0.00168	CcSEcCtD
Treprostinil—Back pain—Epirubicin—sarcoma	0.00114	0.00168	CcSEcCtD
Treprostinil—Dizziness—Etoposide—sarcoma	0.00114	0.00167	CcSEcCtD
Treprostinil—Muscle spasms—Epirubicin—sarcoma	0.00114	0.00167	CcSEcCtD
Treprostinil—Ill-defined disorder—Epirubicin—sarcoma	0.0011	0.00161	CcSEcCtD
Treprostinil—Vomiting—Etoposide—sarcoma	0.00109	0.0016	CcSEcCtD
Treprostinil—Erythema—Doxorubicin—sarcoma	0.00109	0.0016	CcSEcCtD
Treprostinil—Anaemia—Epirubicin—sarcoma	0.00109	0.0016	CcSEcCtD
Treprostinil—Rash—Etoposide—sarcoma	0.00109	0.00159	CcSEcCtD
Treprostinil—Dermatitis—Etoposide—sarcoma	0.00108	0.00159	CcSEcCtD
Treprostinil—Headache—Etoposide—sarcoma	0.00108	0.00158	CcSEcCtD
Treprostinil—Tension—Doxorubicin—sarcoma	0.00107	0.00157	CcSEcCtD
Treprostinil—Malaise—Epirubicin—sarcoma	0.00107	0.00156	CcSEcCtD
Treprostinil—Nervousness—Doxorubicin—sarcoma	0.00106	0.00156	CcSEcCtD
Treprostinil—Syncope—Epirubicin—sarcoma	0.00106	0.00155	CcSEcCtD
Treprostinil—Back pain—Doxorubicin—sarcoma	0.00106	0.00155	CcSEcCtD
Treprostinil—Muscle spasms—Doxorubicin—sarcoma	0.00105	0.00154	CcSEcCtD
Treprostinil—Palpitations—Epirubicin—sarcoma	0.00104	0.00153	CcSEcCtD
Treprostinil—Loss of consciousness—Epirubicin—sarcoma	0.00104	0.00152	CcSEcCtD
Treprostinil—Cough—Epirubicin—sarcoma	0.00103	0.00151	CcSEcCtD
Treprostinil—Nausea—Etoposide—sarcoma	0.00102	0.0015	CcSEcCtD
Treprostinil—Ill-defined disorder—Doxorubicin—sarcoma	0.00102	0.00149	CcSEcCtD
Treprostinil—Anaemia—Doxorubicin—sarcoma	0.00101	0.00148	CcSEcCtD
Treprostinil—Chest pain—Epirubicin—sarcoma	0.00101	0.00148	CcSEcCtD
Treprostinil—Arthralgia—Epirubicin—sarcoma	0.00101	0.00148	CcSEcCtD
Treprostinil—Myalgia—Epirubicin—sarcoma	0.00101	0.00148	CcSEcCtD
Treprostinil—Anxiety—Epirubicin—sarcoma	0.001	0.00147	CcSEcCtD
Treprostinil—Discomfort—Epirubicin—sarcoma	0.000995	0.00146	CcSEcCtD
Treprostinil—Malaise—Doxorubicin—sarcoma	0.000987	0.00145	CcSEcCtD
Treprostinil—Syncope—Doxorubicin—sarcoma	0.000981	0.00144	CcSEcCtD
Treprostinil—Palpitations—Doxorubicin—sarcoma	0.000967	0.00142	CcSEcCtD
Treprostinil—Oedema—Epirubicin—sarcoma	0.000965	0.00141	CcSEcCtD
Treprostinil—Loss of consciousness—Doxorubicin—sarcoma	0.000962	0.00141	CcSEcCtD
Treprostinil—Infection—Epirubicin—sarcoma	0.000959	0.00141	CcSEcCtD
Treprostinil—Cough—Doxorubicin—sarcoma	0.000955	0.0014	CcSEcCtD
Treprostinil—Shock—Epirubicin—sarcoma	0.000949	0.00139	CcSEcCtD
Treprostinil—Thrombocytopenia—Epirubicin—sarcoma	0.000945	0.00138	CcSEcCtD
Treprostinil—Tachycardia—Epirubicin—sarcoma	0.000942	0.00138	CcSEcCtD
Treprostinil—Arthralgia—Doxorubicin—sarcoma	0.000931	0.00137	CcSEcCtD
Treprostinil—Myalgia—Doxorubicin—sarcoma	0.000931	0.00137	CcSEcCtD
Treprostinil—Chest pain—Doxorubicin—sarcoma	0.000931	0.00137	CcSEcCtD
Treprostinil—Anxiety—Doxorubicin—sarcoma	0.000928	0.00136	CcSEcCtD
Treprostinil—Discomfort—Doxorubicin—sarcoma	0.00092	0.00135	CcSEcCtD
Treprostinil—Anorexia—Epirubicin—sarcoma	0.00092	0.00135	CcSEcCtD
Treprostinil—Hypotension—Epirubicin—sarcoma	0.000902	0.00132	CcSEcCtD
Treprostinil—Oedema—Doxorubicin—sarcoma	0.000893	0.00131	CcSEcCtD
Treprostinil—Infection—Doxorubicin—sarcoma	0.000887	0.0013	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000879	0.00129	CcSEcCtD
Treprostinil—Shock—Doxorubicin—sarcoma	0.000878	0.00129	CcSEcCtD
Treprostinil—Thrombocytopenia—Doxorubicin—sarcoma	0.000874	0.00128	CcSEcCtD
Treprostinil—Insomnia—Epirubicin—sarcoma	0.000873	0.00128	CcSEcCtD
Treprostinil—Tachycardia—Doxorubicin—sarcoma	0.000871	0.00128	CcSEcCtD
Treprostinil—Paraesthesia—Epirubicin—sarcoma	0.000866	0.00127	CcSEcCtD
Treprostinil—Dyspnoea—Epirubicin—sarcoma	0.00086	0.00126	CcSEcCtD
Treprostinil—Anorexia—Doxorubicin—sarcoma	0.000851	0.00125	CcSEcCtD
Treprostinil—Dyspepsia—Epirubicin—sarcoma	0.000849	0.00124	CcSEcCtD
Treprostinil—Decreased appetite—Epirubicin—sarcoma	0.000839	0.00123	CcSEcCtD
Treprostinil—Hypotension—Doxorubicin—sarcoma	0.000834	0.00122	CcSEcCtD
Treprostinil—Fatigue—Epirubicin—sarcoma	0.000832	0.00122	CcSEcCtD
Treprostinil—Pain—Epirubicin—sarcoma	0.000825	0.00121	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000813	0.00119	CcSEcCtD
Treprostinil—Insomnia—Doxorubicin—sarcoma	0.000808	0.00118	CcSEcCtD
Treprostinil—Paraesthesia—Doxorubicin—sarcoma	0.000802	0.00118	CcSEcCtD
Treprostinil—Dyspnoea—Doxorubicin—sarcoma	0.000796	0.00117	CcSEcCtD
Treprostinil—Feeling abnormal—Epirubicin—sarcoma	0.000795	0.00117	CcSEcCtD
Treprostinil—Gastrointestinal pain—Epirubicin—sarcoma	0.000789	0.00116	CcSEcCtD
Treprostinil—Dyspepsia—Doxorubicin—sarcoma	0.000786	0.00115	CcSEcCtD
Treprostinil—Decreased appetite—Doxorubicin—sarcoma	0.000776	0.00114	CcSEcCtD
Treprostinil—Fatigue—Doxorubicin—sarcoma	0.00077	0.00113	CcSEcCtD
Treprostinil—Pain—Doxorubicin—sarcoma	0.000764	0.00112	CcSEcCtD
Treprostinil—Abdominal pain—Epirubicin—sarcoma	0.000763	0.00112	CcSEcCtD
Treprostinil—Body temperature increased—Epirubicin—sarcoma	0.000763	0.00112	CcSEcCtD
Treprostinil—Feeling abnormal—Doxorubicin—sarcoma	0.000736	0.00108	CcSEcCtD
Treprostinil—Gastrointestinal pain—Doxorubicin—sarcoma	0.00073	0.00107	CcSEcCtD
Treprostinil—Abdominal pain—Doxorubicin—sarcoma	0.000706	0.00103	CcSEcCtD
Treprostinil—Body temperature increased—Doxorubicin—sarcoma	0.000706	0.00103	CcSEcCtD
Treprostinil—Asthenia—Epirubicin—sarcoma	0.000692	0.00101	CcSEcCtD
Treprostinil—Pruritus—Epirubicin—sarcoma	0.000683	0.001	CcSEcCtD
Treprostinil—Diarrhoea—Epirubicin—sarcoma	0.00066	0.000968	CcSEcCtD
Treprostinil—Asthenia—Doxorubicin—sarcoma	0.000641	0.000939	CcSEcCtD
Treprostinil—Dizziness—Epirubicin—sarcoma	0.000638	0.000935	CcSEcCtD
Treprostinil—Pruritus—Doxorubicin—sarcoma	0.000632	0.000926	CcSEcCtD
Treprostinil—Vomiting—Epirubicin—sarcoma	0.000614	0.000899	CcSEcCtD
Treprostinil—Diarrhoea—Doxorubicin—sarcoma	0.000611	0.000895	CcSEcCtD
Treprostinil—Rash—Epirubicin—sarcoma	0.000608	0.000892	CcSEcCtD
Treprostinil—Dermatitis—Epirubicin—sarcoma	0.000608	0.000891	CcSEcCtD
Treprostinil—Headache—Epirubicin—sarcoma	0.000605	0.000886	CcSEcCtD
Treprostinil—Dizziness—Doxorubicin—sarcoma	0.00059	0.000865	CcSEcCtD
Treprostinil—Nausea—Epirubicin—sarcoma	0.000573	0.00084	CcSEcCtD
Treprostinil—Vomiting—Doxorubicin—sarcoma	0.000568	0.000832	CcSEcCtD
Treprostinil—Rash—Doxorubicin—sarcoma	0.000563	0.000825	CcSEcCtD
Treprostinil—Dermatitis—Doxorubicin—sarcoma	0.000562	0.000824	CcSEcCtD
Treprostinil—Headache—Doxorubicin—sarcoma	0.000559	0.00082	CcSEcCtD
Treprostinil—Nausea—Doxorubicin—sarcoma	0.00053	0.000777	CcSEcCtD
Treprostinil—PPARD—Ectoderm Differentiation—PTPRB—sarcoma	0.000526	0.157	CbGpPWpGaD
Treprostinil—PPARD—Presenilin action in Notch and Wnt signaling—TLE1—sarcoma	0.000309	0.0921	CbGpPWpGaD
Treprostinil—PPARD—Ectoderm Differentiation—PAX3—sarcoma	0.000218	0.0651	CbGpPWpGaD
Treprostinil—P2RY12—Signal amplification—SRC—sarcoma	9.23e-05	0.0275	CbGpPWpGaD
Treprostinil—PPARD—Presenilin action in Notch and Wnt signaling—CCND1—sarcoma	7.6e-05	0.0226	CbGpPWpGaD
Treprostinil—PPARD—Presenilin action in Notch and Wnt signaling—JUN—sarcoma	7.59e-05	0.0226	CbGpPWpGaD
Treprostinil—PPARD—Presenilin action in Notch and Wnt signaling—CTNNB1—sarcoma	7.53e-05	0.0224	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—VEGFC—sarcoma	7.35e-05	0.0219	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—FOXO1—sarcoma	6.33e-05	0.0189	CbGpPWpGaD
Treprostinil—PPARD—Presenilin action in Notch and Wnt signaling—MYC—sarcoma	6.1e-05	0.0182	CbGpPWpGaD
Treprostinil—PTGIR—Thromboxane A2 receptor signaling—SRC—sarcoma	5.3e-05	0.0158	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—CXCR4—sarcoma	5.29e-05	0.0157	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—TEK—sarcoma	5.16e-05	0.0154	CbGpPWpGaD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—CXCR4—sarcoma	4.91e-05	0.0146	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—TEK—sarcoma	4.75e-05	0.0142	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—ANGPT2—sarcoma	4.72e-05	0.0141	CbGpPWpGaD
Treprostinil—PTGIR—Thromboxane A2 receptor signaling—EGFR—sarcoma	4.64e-05	0.0138	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—CREB1—sarcoma	4.59e-05	0.0137	CbGpPWpGaD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—CXCR4—sarcoma	4.51e-05	0.0134	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—ANGPT2—sarcoma	4.35e-05	0.0129	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	4.2e-05	0.0125	CbGpPWpGaD
Treprostinil—PPARD—Wnt Signaling Pathway and Pluripotency—CCND1—sarcoma	4.02e-05	0.012	CbGpPWpGaD
Treprostinil—PPARD—Wnt Signaling Pathway and Pluripotency—JUN—sarcoma	4.01e-05	0.0119	CbGpPWpGaD
Treprostinil—PPARD—Wnt Signaling Pathway and Pluripotency—CTNNB1—sarcoma	3.98e-05	0.0119	CbGpPWpGaD
Treprostinil—CYP2C9—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	3.91e-05	0.0116	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	3.87e-05	0.0115	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—VEGFC—sarcoma	3.79e-05	0.0113	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—FUS—sarcoma	3.59e-05	0.0107	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—VEGFC—sarcoma	3.49e-05	0.0104	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—CTNNB1—sarcoma	3.28e-05	0.00977	CbGpPWpGaD
Treprostinil—PPARD—Wnt Signaling Pathway and Pluripotency—MYC—sarcoma	3.22e-05	0.0096	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—CXCR4—sarcoma	3.2e-05	0.00953	CbGpPWpGaD
Treprostinil—PPARD—Ectoderm Differentiation—CTNNB1—sarcoma	3.13e-05	0.00931	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—PLCG1—sarcoma	2.98e-05	0.00887	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—CXCR4—sarcoma	2.95e-05	0.00877	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—PLCG1—sarcoma	2.74e-05	0.00816	CbGpPWpGaD
Treprostinil—PPARD—Wnt Signaling Pathway and Pluripotency—TP53—sarcoma	2.65e-05	0.00789	CbGpPWpGaD
Treprostinil—PPARD—Ectoderm Differentiation—MYC—sarcoma	2.53e-05	0.00754	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—IL2—sarcoma	2.2e-05	0.00655	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—SRC—sarcoma	1.92e-05	0.00571	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—VEGFA—sarcoma	1.87e-05	0.00557	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CXCR4—sarcoma	1.81e-05	0.00539	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CXCR4—sarcoma	1.66e-05	0.00496	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CXCR4—sarcoma	1.64e-05	0.00489	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TLE1—sarcoma	1.52e-05	0.00454	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CXCR4—sarcoma	1.51e-05	0.0045	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ENO2—sarcoma	1.44e-05	0.00428	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—HBA1—sarcoma	1.43e-05	0.00426	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TLE1—sarcoma	1.4e-05	0.00418	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—VEGFC—sarcoma	1.29e-05	0.00383	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PLCG1—sarcoma	1.22e-05	0.00363	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—VEGFC—sarcoma	1.18e-05	0.00352	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—IL2—sarcoma	1.13e-05	0.00338	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—IL2—sarcoma	1.04e-05	0.00311	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—FLT1—sarcoma	1.03e-05	0.00306	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PLCG1—sarcoma	1.01e-05	0.00301	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—SRC—sarcoma	9.89e-06	0.00295	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CXCR4—sarcoma	9.7e-06	0.00289	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—MYC—sarcoma	9.7e-06	0.00289	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—VEGFA—sarcoma	9.63e-06	0.00287	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ATF1—sarcoma	9.59e-06	0.00286	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—NRAS—sarcoma	9.51e-06	0.00283	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FLT1—sarcoma	9.46e-06	0.00282	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PLCG1—sarcoma	9.29e-06	0.00277	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—SRC—sarcoma	9.1e-06	0.00271	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CXCR4—sarcoma	8.93e-06	0.00266	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—VEGFA—sarcoma	8.86e-06	0.00264	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ATF1—sarcoma	8.83e-06	0.00263	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CREB1—sarcoma	8.8e-06	0.00262	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—NRAS—sarcoma	8.76e-06	0.00261	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—KRAS—sarcoma	8.19e-06	0.00244	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CREB1—sarcoma	8.1e-06	0.00241	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—KRAS—sarcoma	7.54e-06	0.00224	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IGF1R—sarcoma	7.53e-06	0.00224	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—TP53—sarcoma	7.28e-06	0.00217	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—FOXO1—sarcoma	7.17e-06	0.00213	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—IL2—sarcoma	7.16e-06	0.00213	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PDGFRB—sarcoma	7.15e-06	0.00213	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PDGFRA—sarcoma	7.04e-06	0.0021	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—HRAS—sarcoma	6.96e-06	0.00207	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IGF1R—sarcoma	6.93e-06	0.00206	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—TP53—sarcoma	6.7e-06	0.00199	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FOXO1—sarcoma	6.59e-06	0.00196	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—IL2—sarcoma	6.59e-06	0.00196	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PDGFRB—sarcoma	6.58e-06	0.00196	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL2—sarcoma	6.5e-06	0.00194	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PDGFRA—sarcoma	6.48e-06	0.00193	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—HRAS—sarcoma	6.41e-06	0.00191	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL2—sarcoma	5.99e-06	0.00178	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—KDR—sarcoma	5.93e-06	0.00177	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—KIT—sarcoma	5.46e-06	0.00163	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—NRAS—sarcoma	5.46e-06	0.00163	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—KDR—sarcoma	5.45e-06	0.00162	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CREB1—sarcoma	5.2e-06	0.00155	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—KIT—sarcoma	5.02e-06	0.0015	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—NRAS—sarcoma	5.02e-06	0.0015	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—EGFR—sarcoma	4.97e-06	0.00148	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CREB1—sarcoma	4.78e-06	0.00142	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—KRAS—sarcoma	4.7e-06	0.0014	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—MYC—sarcoma	4.67e-06	0.00139	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—EGFR—sarcoma	4.58e-06	0.00136	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—KRAS—sarcoma	4.32e-06	0.00129	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MDM2—sarcoma	4.3e-06	0.00128	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—HRAS—sarcoma	3.99e-06	0.00119	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MDM2—sarcoma	3.96e-06	0.00118	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL2—sarcoma	3.84e-06	0.00114	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCND1—sarcoma	3.75e-06	0.00112	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—JUN—sarcoma	3.74e-06	0.00111	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CTNNB1—sarcoma	3.71e-06	0.0011	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—HRAS—sarcoma	3.68e-06	0.00109	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL2—sarcoma	3.54e-06	0.00105	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCND1—sarcoma	3.45e-06	0.00103	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—JUN—sarcoma	3.44e-06	0.00102	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CTNNB1—sarcoma	3.41e-06	0.00102	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SRC—sarcoma	3.35e-06	0.000999	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—VEGFA—sarcoma	3.27e-06	0.000973	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NRAS—sarcoma	3.23e-06	0.000961	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SRC—sarcoma	3.09e-06	0.000919	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—VEGFA—sarcoma	3.01e-06	0.000895	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MYC—sarcoma	3e-06	0.000895	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NRAS—sarcoma	2.97e-06	0.000884	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—EGFR—sarcoma	2.94e-06	0.000875	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ENO2—sarcoma	2.89e-06	0.000861	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HBA1—sarcoma	2.87e-06	0.000856	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—KRAS—sarcoma	2.78e-06	0.000827	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MYC—sarcoma	2.76e-06	0.000823	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—EGFR—sarcoma	2.7e-06	0.000805	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—KRAS—sarcoma	2.55e-06	0.000761	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TP53—sarcoma	2.47e-06	0.000735	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PLCG1—sarcoma	2.45e-06	0.000731	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HRAS—sarcoma	2.36e-06	0.000703	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TP53—sarcoma	2.27e-06	0.000676	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HRAS—sarcoma	2.17e-06	0.000647	CbGpPWpGaD
